Summit Partners Public Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-379,150
| Closed | -$46.1M | – | 123 |
|
|
2024
Q4 | $46.1M | Buy |
379,150
+241,032
| +175% | +$29.3M | 0.88% | 26 |
|
|
2024
Q3 | $17.2M | Buy |
138,118
+116,800
| +548% | +$14.6M | 0.53% | 43 |
|
|
2024
Q2 | $3.37M | Buy |
+21,318
| New | +$3.37M | 0.13% | 62 |
|
|
2023
Q4 | – | Sell |
-44,319
| Closed | -$5.37M | – | 131 |
|
|
2023
Q3 | $5.37M | Sell |
44,319
-304,276
| -87% | -$36.9M | 0.23% | 52 |
|
|
2023
Q2 | $39.9M | Buy |
348,595
+180,386
| +107% | +$20.7M | 1.48% | 18 |
|
|
2023
Q1 | $23.2M | Buy |
168,209
+1,219
| +0.7% | +$168K | 0.95% | 34 |
|
|
2022
Q4 | $21.6M | Buy |
+166,990
| New | +$21.6M | 1.37% | 28 |
|
|
2019
Q1 | – | Sell |
-82,327
| Closed | -$8.98M | – | 69 |
|
|
2018
Q4 | $8.98M | Buy |
82,327
+1,253
| +2% | +$137K | 1.22% | 19 |
|
|
2018
Q3 | $13.1M | Buy |
81,074
+23,074
| +40% | +$3.73M | 0.89% | 32 |
|
|
2018
Q2 | $7.67M | Sell |
58,000
-62,000
| -52% | -$8.19M | 0.85% | 32 |
|
|
2018
Q1 | $8.89M | Sell |
120,000
-35,000
| -23% | -$2.59M | 1.26% | 29 |
|
|
2017
Q4 | $8.62M | Buy |
+155,000
| New | +$8.62M | 1.13% | 28 |
|